HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

470.946

+1.8350.39%

Number of Gainers:16

Number of Losers:28

Number of Flat:7

PE:- -

High:471.885

Open:468.227

Low:465.418

Close:469.111

Volume:174.01M

Turnover:5.15B

Market Cap:2.96T

Float Cap:2.07T

Loading ...

Grand Pharmaceutical H1 Revenue Rises on Nuclear Medicine Demand

Microport Scientific - Shanghai Microport Endovascular Medtech Hy Revenue of Rmb793.95 Mln

THOMSON REUTERS

Conch Cement Reports Interim Results with 41.85% Decline in Shareholder Profit

Lee's Pharmaceutical Flags Higher Interim Profit as Revenue and Margins Improve

Hansoh Pharmaceutical Cuts Convertible Bond Conversion Price to Hk$56.54 Per Share

AK MEDICAL Reports 22.5% Profit Surge in Interim Results

AK Medical Holdings H1 Net Income Attributable RMB 196.7 Million

THOMSON REUTERS

AK Medical FY26 H1 Profit Rises 22.5% to RMB 196.72 Million; Revenue Climbs 10.2% to RMB 764.73 Million

BAIRONG AI-W (06608) Finalizes Placement of 37.39 Million Warrants

Bairong Completes Placement of 37,393,500 Non-Listed Warrants at Hk$0.29 Each

China's Zhongzhi Pharmaceutical H1 Revenue Falls 10%

Xtep (SEHK:1368) Stock Can Premium Running Offset Softer Earnings

Simply Wall St.

Nomura Adjusts Xtep International Holdings' Price Target to HK$3.90 From HK$4.20, Keeps at Neutral

MT Newswires Live

China's Jiangsu Says it Will Support Pharmaceutical Firms' Global M&A, Licensing

Beone Medicines' First-Half Profit Surges 386% as Core Drug Drives Revenue Past $3.2 Billion

RemeGen (SEHK:9995) Stock Profit Surge Meets Doubts Over Earnings Durability

Simply Wall St.

Xinyi Solar Unit Xinyi Energy Plans Sale or Injection of Solar Farms into PRC-Listed REIT

Xinyi Energy - Proposed PRC Listing of Xinyi Energy New Energy REIT Recommended by Ndrc to Csrc

THOMSON REUTERS

Uni-Bio Science H1 Revenue Falls 12% on Pricing Changes

BEONE MEDICINES Reports Strong First-Half Profit Surge of 385.8%

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/BK1583/news?page=13"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"Hillhouse Capital Related","latestPrice":470.94595,"timestamp":1788321599848,"preClose":469.11102,"halted":0,"volume":174008975,"delay":0,"changeRate":0.003912,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Noon Closed","change":1.83493,"latestTime":"09-02 12:00:00","open":468.22687,"high":471.8846,"low":465.4181,"amount":5148273278,"amplitude":0.013785,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788325200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1788312600000,1788321600000],[1788325200000,1788336000000]],"pbRate":2.123393,"peRate":44.857386,"turnoverRate":0.001694,"increases":16,"decrements":28,"flats":5,"marketCap":2955664031360,"floatMarketCap":2070884204672},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":471.8846,"amplitude":0.013785,"preClose":469.11102,"low":465.4181,"pbRate":"2.123393","latestPrice":470.94595,"volume":174008975,"delay":0,"open":468.22687,"prevYearClose":503.90085,"prevWeekClose":483.681,"prevMonthClose":473.951,"prevQuarterClose":402.118,"fiveDayClose":483.092,"twentyDayClose":476.028,"sixtyDayClose":414.418,"secType":"PLATE","market":"HK","turnoverRate":0.001694,"peRate":44.857386,"marketCap":2955664031360,"floatMarketCap":2070884204672,"timestamp":1788321599848,"nameCN":"Hillhouse Capital Related"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":16,"down":28,"flat":7},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:13,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662717592","title":"Grand Pharmaceutical H1 Revenue Rises on Nuclear Medicine Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2662717592","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662717592?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:54","pubTimestamp":1787752465,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical H1 revenue rises on nuclear medicine demandOverviewHong Kong-listed pharma group's H1 revenue rose 3.2% yr/yr to HK$6.39 blnNet income attributable to owners fell to HK$1.06 bln f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N0MX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1600","BK1589","BK1515","00512","BK1191","00460","03692","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662173427","title":"Microport Scientific - Shanghai Microport Endovascular Medtech Hy Revenue of Rmb793.95 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662173427","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662173427?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:50","pubTimestamp":1787752239,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0NK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1100","BK1585","BK1583","00853","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116288019","title":"Conch Cement Reports Interim Results with 41.85% Decline in Shareholder Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=1116288019","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116288019?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:30","pubTimestamp":1787751055,"startTime":"0","endTime":"0","summary":"Conch Cement (00914) has released its interim results for the six-month period ended June 30, 2026. The group recorded operating revenue of RMB 36.927 billion, a year-on-year decrease of 10.88%....","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1594","00914","BK0044","BK0235","BK1563","BK0196","BK0015","BK0188","LU1328615791.USD","BK0183","600585","BK1583","BK0028","BK0187","BK1507","BK1505","BK1135","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184470015","title":"Lee's Pharmaceutical Flags Higher Interim Profit as Revenue and Margins Improve","url":"https://stock-news.laohu8.com/highlight/detail?id=1184470015","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184470015?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:28","pubTimestamp":1787750895,"startTime":"0","endTime":"0","summary":"Lee's Pharmaceutical Holdings Ltd (00950) has issued a positive profit alert, indicating that the group expects to report an audited net profit attributable to shareholders of between approximately...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","00950","06622","BK1583","BK1191","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662279711","title":"Hansoh Pharmaceutical Cuts Convertible Bond Conversion Price to Hk$56.54 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2662279711","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662279711?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:46","pubTimestamp":1787748384,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical cuts convertible bond conversion price to HK$56.54 per shareHansoh Pharmaceutical adjusted the conversion price on its HK$ 4.68 billion zero-coupon convertible bonds due 2033.Con","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDLc9h2j6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03692","BK1583","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170704019","title":"AK MEDICAL Reports 22.5% Profit Surge in Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1170704019","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170704019?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:32","pubTimestamp":1787747544,"startTime":"0","endTime":"0","summary":"AK MEDICAL (01789) has released its interim results for the 2026 fiscal year, posting a revenue of approximately HK$765 million, reflecting a year-on-year increase of 10.2%.The company's profit...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01789","BK1583","BK1585","BK1100","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662719438","title":"AK Medical Holdings H1 Net Income Attributable RMB 196.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662719438","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662719438?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:20","pubTimestamp":1787746844,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nPLX2N4ZLZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1585","BK1583","BK1100","BK1617","01789"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662719443","title":"AK Medical FY26 H1 Profit Rises 22.5% to RMB 196.72 Million; Revenue Climbs 10.2% to RMB 764.73 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662719443","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662719443?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:20","pubTimestamp":1787746844,"startTime":"0","endTime":"0","summary":"AK Medical FY26 H1 profit rises 22.5% to RMB 196.72 million; revenue climbs 10.2% to RMB 764.73 millionAK Medical posted profit attributable to equity shareholders of RMB 196.72 million, up 22.5%, wit","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDLblfxzP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1585","BK1617","01789","BK1583","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187859653","title":"BAIRONG AI-W (06608) Finalizes Placement of 37.39 Million Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=1187859653","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187859653?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:00","pubTimestamp":1787745623,"startTime":"0","endTime":"0","summary":"BAIRONG AI-W (06608) has announced that all conditions precedent for the placement have been fulfilled, and the placement was completed on August 26, 2026, in accordance with the terms and conditions...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1109","BK1575","BK1587","06608","BK1131"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662716305","title":"Bairong Completes Placement of 37,393,500 Non-Listed Warrants at Hk$0.29 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2662716305","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662716305?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:55","pubTimestamp":1787745353,"startTime":"0","endTime":"0","summary":"Bairong completes placement of 37,393,500 non-listed warrants at HK$0.29 eachBairong completed a placing of 37,393,500 non-listed warrants under a specific mandate on Aug. 26, 2026.Warrants placed at ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL370TWx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06608","BK1575","BK1131","BK1583","BK1109","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662715194","title":"China's Zhongzhi Pharmaceutical H1 Revenue Falls 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662715194","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662715194?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:36","pubTimestamp":1787744170,"startTime":"0","endTime":"0","summary":"China's Zhongzhi Pharmaceutical H1 revenue falls 10%OverviewChina pharmaceutical maker's half-year revenue fell 10.3% yr/yrProfit attributable to owners rose 3.8% yr/yrGross profit and margin declined","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N0G0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1606","BK1589","BK1515","01681","BK1600","03737","00460","BK1583","BK1593","BK1191","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662714005","title":"Xtep (SEHK:1368) Stock Can Premium Running Offset Softer Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2662714005","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662714005?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:34","pubTimestamp":1787744093,"startTime":"0","endTime":"0","summary":"Xtep International Holdings entered these results with a stock that had drifted, rising about 6% over the past week but still showing a weaker 90-day stretch. The headline today is straightforward: the market is looking at a low P/E of 6.9x and a high dividend yield near 7.7%, while the latest half year shows solid profitability with net income of RMB 817.9m.\nThe question for investors is whether the sharp discount to a DCF value near HK$15.90 and the raised interim dividend reflect caution...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/4131000-choice1-main-header/1585186707756","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4131000-choice1-main-header/1585186707756"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/consumer-durables/hkg-1368/xtep-international-holdings-shares/news/xtep-sehk1368-stock-can-premium-running-offset-softer-earnin","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/consumer-durables/hkg-1368/xtep-international-holdings-shares/news/xtep-sehk1368-stock-can-premium-running-offset-softer-earnin","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["01368","BK1512","BK4588","LU0702159343.USD","BK1583","BK1168","BK1502","SPHQ","BK4585","LU1166156734.SGD","VIG","LU0702159699.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662715846","title":"Nomura Adjusts Xtep International Holdings' Price Target to HK$3.90 From HK$4.20, Keeps at Neutral","url":"https://stock-news.laohu8.com/highlight/detail?id=2662715846","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662715846?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:21","pubTimestamp":1787743290,"startTime":"0","endTime":"0","summary":"Xtep International Holdings (HKG:1368) has an average rating of buy and mean price target of HK$4.85, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic resear","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01368","LU0702159699.USD","BK1512","BK1168","BK1502","BK1583","LU1166156734.SGD","LU0702159343.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662444718","title":"China's Jiangsu Says it Will Support Pharmaceutical Firms' Global M&A, Licensing","url":"https://stock-news.laohu8.com/highlight/detail?id=2662444718","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662444718?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:58","pubTimestamp":1787741906,"startTime":"0","endTime":"0","summary":"UPDATE 2-China's Jiangsu says it will support pharmaceutical firms' global M&A, licensingSHANGHAI, Aug 26 (Reuters)-Chinese biotech hub Jiangsu province pledged to support pharmaceutical companies see","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL6N44N0KV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2495084118.USD","BK0188","LU1655091616.SGD","LU0405327148.USD","LU2488822045.USD","LU2580892789.USD","LU1997245094.SGD","BK0012","KURE","LU2097828557.USD","HK0000165453.HKD","LU0502904849.HKD","LU0244354667.USD","LU2148510915.USD","BK0196","LU1997245177.USD","LU1328615791.USD","LU1146622755.USD","BK0183","BK1589","LU1064131003.USD","LU1820825898.SGD","BK0028","LU0405327494.USD","LU1580142542.USD","LU2242644610.SGD","01801","LU1997244956.HKD","LU2328871848.SGD","LU2580892862.HKD","LU1188198961.HKD","LU1255011170.USD","LU2097828631.EUR","LU0463099449.HKD","LU1781817850.SGD","LU2097828714.EUR","LU0455707207.USD","BK0060","LU2097828474.EUR","LU1969619763.USD","LU1064130708.USD","BK0239","LU2289578879.USD","LU0326950275.SGD","BK1583","LU2097828805.USD","BK1161","600276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141434847","title":"Beone Medicines' First-Half Profit Surges 386% as Core Drug Drives Revenue Past $3.2 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1141434847","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141434847?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:44","pubTimestamp":1787741086,"startTime":"0","endTime":"0","summary":"Beone Medicines has delivered a stellar first-half performance for fiscal 2026, with profitability climbing sharply year-on-year and validating the effectiveness of its commercial strategy.According...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK1588","LU1251922891.USD","KURE","LU1303224171.USD","LU0588546209.SGD","LU0228659784.USD","LU0828237510.HKD","LU1719994722.HKD","LU1770034418.SGD","LU2328871848.SGD","BK4139","ONC","LU1969619763.USD","BK4526","BK1500","688235","06160","BK0239","LU0307460666.USD","BK1583","BK4585","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662184712","title":"RemeGen (SEHK:9995) Stock Profit Surge Meets Doubts Over Earnings Durability","url":"https://stock-news.laohu8.com/highlight/detail?id=2662184712","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662184712?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:43","pubTimestamp":1787741007,"startTime":"0","endTime":"0","summary":"RemeGen stock closed at HK$80.40 on Wednesday, only slightly higher over the past week, even as the latest earnings landed with a jolt. The headline is simple: profitability in Q2 looks striking on paper, with basic earnings per share of ¥7.81 driven by net income of ¥4,334.28m. Yet the stock still trades on a trailing P/E of 6.6x while Hong Kong biotech peers sit far higher. The sentiment gap today relates to investors questioning how much of that earnings power is durable and how much the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/remegen-sehk9995-stock-profit-surge-meets-doubts-over-earnin","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/remegen-sehk9995-stock-profit-surge-meets-doubts-over-earnin","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VGFPF","FEBU","RGLO","VOTE","PMDE","BK1583","DECU","JOYT","BK1574","LU1969619763.USD","LU2328871848.SGD","GXDW","BK1161","09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662579703","title":"Xinyi Solar Unit Xinyi Energy Plans Sale or Injection of Solar Farms into PRC-Listed REIT","url":"https://stock-news.laohu8.com/highlight/detail?id=2662579703","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662579703?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:24","pubTimestamp":1787739845,"startTime":"0","endTime":"0","summary":"Xinyi Solar unit Xinyi Energy plans sale or injection of solar farms into PRC-listed REITXinyi Solar disclosed a proposed PRC listing of Xinyi Energy New Energy REIT, involving selected solar farm pro","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL7llm2X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03868","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","BK1594","BK1589","BK1154","LU1983299162.USD","IE00BZ08YT58.USD","00968","BK1169","BK1583","BK1554"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662977827","title":"Xinyi Energy - Proposed PRC Listing of Xinyi Energy New Energy REIT Recommended by Ndrc to Csrc","url":"https://stock-news.laohu8.com/highlight/detail?id=2662977827","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662977827?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:21","pubTimestamp":1787739716,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0FD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1594","BK1583","03868","BK1554","BK1154"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662797145","title":"Uni-Bio Science H1 Revenue Falls 12% on Pricing Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2662797145","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662797145?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:18","pubTimestamp":1787739506,"startTime":"0","endTime":"0","summary":"Uni-Bio Science H1 revenue falls 12% on pricing changesOverviewHong Kong-listed biopharma firm's H1 2026 revenue fell 12% yr/yr amid pricing adjustmentsNet profit dropped 59% as R+D and commercializat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N0D4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211328371.USD","KURE","BK1191","LU0234572021.USD","00690","LU0211327993.USD","FHLC","IE0002270589.USD","ABBV","LU0868494708.USD","01801","TRUH","LU2129689605.HKD","IE00BSNM7G36.USD","LU0203345920.USD","LU2133065610.SGD","LU0122379950.USD","BK1583","IE0009355771.USD","IE00B2B36J28.USD","JDOC","PPH","VHT","BK4581","AGNG","LU1934455277.USD","MEDX","IYH","PJP","LU0985320562.USD","BK4588","BK4533","IXJ","XLV","LU0057025933.USD","LU1989772840.SGD","RXL","688331","FTXH","LU0820561909.HKD","GLAM","LU2347655073.USD","IE000BZT7R73.USD","IE000MB6IJN5.SGD","03692","LU0203347892.USD","IE00BLSP4452.SGD","IE000WAW04H5.SGD","IE00B19Z3581.USD","SG9999015986.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107537379","title":"BEONE MEDICINES Reports Strong First-Half Profit Surge of 385.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1107537379","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107537379?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:16","pubTimestamp":1787739404,"startTime":"0","endTime":"0","summary":"BEONE MEDICINES (06160) has unveiled its interim results for the six months ended June 30, 2026, posting a net profit of $464 million, a substantial year-on-year increase of 385.8%.The company's...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1770034418.SGD","LU2328871848.SGD","BK1583","LU1969619763.USD","BK0239","BK4526","BK4585","LU1719994722.HKD","LU0828237510.HKD","LU0307460666.USD","BK4139","BK1161","LU1251922891.USD","LU1303224171.USD","BK1588","LU0588546209.SGD","BK4588","KURE","688235","06160","ONC","LU0228659784.USD","BK1500"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":27,"pageCount":13,"totalSize":535,"code":"91000000","status":"200"}]}}